Cosentyx and Odefsey drug interactions - a phase IV clinical study of FDA data
Summary:
We study 191,852 people who take Cosentyx (secukinumab) and Odefsey (emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate). There is no drug interaction reported.
The study analyzes what interactions people have when they take Cosentyx and Odefsey. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Cosentyx?
Cosentyx has active ingredients of secukinumab. It is often used in psoriatic arthritis. eHealthMe is studying from 187,247 Cosentyx users. Check the latest studies of Cosentyx.
What is Odefsey?
Odefsey has active ingredients of emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 4,605 Odefsey users. Check the latest studies of Odefsey.
No report is found.
Do you take Cosentyx and Odefsey?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
How the study uses the data?
The study uses data from the FDA. It is based on secukinumab and emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate (the active ingredients of Cosentyx and Odefsey, respectively), and Cosentyx and Odefsey (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Lopurin and Oxycodone - a second ago
- Drug interactions of Naproxen and Botox Cosmetic - a second ago
- Magnesium Sulfate and Insomnia for Women aged 40-49 - 2 seconds ago
- Magnesium Sulfate and Can'T Sleep for Women aged 40-49 - 3 seconds ago
- Magnesium Sulfate and Agrypnia for Women aged 40-49 - 3 seconds ago
- Magnesium Sulfate and Insomnia Concerns for Women aged 40-49 - 3 seconds ago
- Magnesium Sulfate and Difficulty Falling Asleep for Women aged 40-49 - 4 seconds ago
- Drug interactions of Erythromycin and Spironolactone - 4 seconds ago
- Magnesium Sulfate and Sleeplessness for Women aged 40-49 - 4 seconds ago
- Magnesium Sulfate and Inability To Sleep for Women aged 40-49 - 4 seconds ago